Stock listing
NASDAQ:SGEN Seagen Inc Stock
Follow Seagen Inc into a list and get an email when it puts out news.
Last close · NASDAQ:SGEN
$228.74 USD
Close on Dec 13, 2023 · No longer trades
- Lowest – highest close
- $2.25 – $228.90 USDSince Mar 7, 2001 · lowest Apr 11, 2003 · highest Dec 12, 2023
Delisted NASDAQ:SGEN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:SGEN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Seagen Inc on 6ix
- Calls
- 9 calls with a replay · 9 with a transcript · latest Feb 15, 2023
- Decks
- 1 deck · latest Mar 13, 2023
Events
| Call | When | Status |
|---|---|---|
| Seagen (SGEN) Q4 2022 Earnings Call | Wed, Feb 15, 2023 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q3 2022 Earnings Call | Thu, Oct 27, 2022 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q2 2022 Earnings Call | Thu, Jul 28, 2022 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q1 2022 Earnings Call | Thu, Apr 28, 2022 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q4 2021 Earnings Call | Wed, Feb 09, 2022 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q3 2021 Earnings Call | Thu, Oct 28, 2021 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q2 2021 Earnings Call | Thu, Jul 29, 2021 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q1 2021 Earnings Call | Thu, Apr 29, 2021 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q4 2020 Earnings Call | Thu, Feb 11, 2021 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (March 2023) | Merger or acquisition | 20 slides | Mar 13, 2023 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Felix Baker Other companies: BeOne Medicines Ltd. Class A (Director · Since at least Nov 6, 2026); Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Chairman · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Lead Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Director · Since at least Jan 4, 2008); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Spyre Therapeutics, Inc. (Director · Feb 23, 2021 – Jun 8, 2021 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Neurogene Inc. (Director · May 8, 2017 – Dec 18, 2023 · Past); Alexion Pharmaceuticals Inc (Director · Jun 22, 2015 – May 14, 2020 · Past); Aceragen Inc. (Director · Mar 10, 2014 – Apr 1, 2019 · Past); Ardea Biosciences Inc (Director · Feb 8, 2010 – Jun 19, 2012 · Past); Synageva BioPharma Corp (Director · Aug 14, 2007 – Jun 22, 2015 · Past); Neurogen Corp (Director · Jun 7, 2007 – Jul 25, 2008 · Past); Genomic Health Inc (Director · May 21, 2007 – Oct 1, 2019 · Past) | Director · May 25, 2007 – Dec 14, 2023 · Past |
| Alpna Seth Other companies: Keros Therapeutics, Inc. (Director · Since at least May 1, 2023); Bio-Techne Corp (Director · Since at least Oct 26, 2017) | Director · Mar 15, 2018 – Dec 14, 2023 · Past |
| David R. Epstein Other companies: AgomAb Therapeutics NV (Chairman of the Board · Since at least Mar 18, 2026); Tempus AI, Inc. (Director · Since at least Jun 13, 2024) | CEO, Director · Nov 10, 2023 – Dec 14, 2023 · Past |
| Jean Liu Other companies: Connect Biopharma Holdings Limited (Board Director · Since at least Mar 16, 2026); Erasca, Inc. (Board Director · Since at least Jan 1, 2024) | Chief Legal Officer · Dec 14, 2023 – Dec 14, 2023 · Past |
| Todd Simpson Other companies: Xencor, Inc. (Director · Since at least Mar 13, 2025); Neurogene Inc. (Director · May 12, 2022 – Jun 8, 2023 · Past) | Chief Financial Officer · Apr 20, 2022 – Dec 14, 2023 · Past |
| Daniel Floyd Hoth Jr Other companies: Aduro Biotech Inc (Interim Chief Medical Officer · Nov 29, 2018 – Nov 29, 2018 · Past) | Director · May 15, 2009 – May 21, 2010 · Past |
| Marc E. Lippman Other companies: Ascentage Pharma Group International (Independent non-executive Director · Since at least Mar 18, 2026) | Director · May 20, 2019 – May 14, 2021 · Past |
| Morris Rosenberg Other companies: Immunomedics Inc (Chief Technology Officer · Apr 12, 2018 – Sep 6, 2019 · Past) | EVP, Process Sciences · Mar 13, 2012 – Jun 12, 2012 · Past |
| Pamela A TrailSmith | Chief Scientific Officer · May 17, 2007 – May 17, 2007 · Past |
Log in to ask 6ix AI your own questions about Seagen Inc.